Peer-led drug prevention
Press release issued: 24 April 2019
Researchers at Bristol and Cardiff universities are running the largest ever trial of a peer-led drug prevention programme in schools across the West of England and South Wales. FRANK Friends will run over three years, across 48 schools, and involve around 5,655 students. It will evaluate the effectiveness and cost-effectiveness of a peer-led programme in preventing drug use among young people.
Year 9 students (aged 13-14) will be asked to nominate other students who they think are influential and those in the top 17.5 per cent of nominations will be asked to become peer supporters. After two days of training, the selected students will be asked to have conversations about the potential harms of drug use with their peers over a ten-week period.
Dr James White, study lead and Chief Investigator of the Centre for Trials Research at Cardiff University and DECIPHer, said: "There is limited evidence that drug prevention interventions are effective. The latest UK data indicate that 37 per cent of 15-year-olds have tried an illicit drug and more than 13,000 11 to 18-year-olds accessed drug treatment in the UK.
"Schools provide a systematic and efficient way of reaching a large number of people every year. This randomised controlled trial is the best way to determine if the FRANK friends intervention prevents drug use among young people."
Randomly split into two groups, 24 schools will receive FRANK friends, and 24 will continue with their usual schooling. The research team will collect information on drug use from all of the participating students before and after the programme is delivered to see if there are positive changes in student drug use, and whether these changes are greater within schools that received the intervention compared to schools that did not. They will also conduct interviews with peer supporters, other students and trainers, and observe training sessions to explore what happened during the training, how people feel about the intervention, and in what ways it has been useful. Finally, they will calculate the cost of the intervention, and weigh this up against any benefits in terms of student drug use, to see if it provides good value for money.
The trial builds on a successful pilot study where an effective school-based peer-led smoking prevention programme (ASSIST) was adapted to deliver information from the UK national drug education website: www.talktofrank.com. Students, teachers, and parents, all thought the intervention was acceptable, easy to deliver and could have promising effects on preventing and reducing drug use.
Study partners include Cardiff University, the Universities of Bristol, Glasgow, York, the London School of Hygiene and Tropical Medicine, Public Health Wales, the West of England Clinical Research Network, South Gloucestershire and Bath and North East Somerset council. FRANK Friends is funded by the National Institute for Health Research (NIHR) Public Health Research Programme.
About the National Institute for Health Research (NIHR)
The NIHR is the nation's largest funder of health and care research. The NIHR:
- Funds, supports and delivers high quality research that benefits the NHS, public health and social care;
- Engages and involves patients, carers and the public in order to improve the reach, quality and impact of research;
- Attracts, trains and supports the best researchers to tackle the complex health and care challenges of the future;
- Invests in world-class infrastructure and a skilled delivery workforce to translate discoveries into improved treatments and services;
- Partners with other public funders, charities and industry to maximise the value of research to patients and the economy.
The NIHR was established in 2006 to improve the health and wealth of the nation through research, and is funded by the Department of Health and Social Care. In addition to its national role, the NIHR commissions applied health research to benefit the poorest people in low- and middle-income countries, using Official Development Assistance funding.